Sectoral Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Sectoral Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,900	Closed	-$409K	–	98
2024 Q4	$409K	Sell	4,900 -1,530	-24%	-$126K	0.27%	59
2024 Q3	$470K	Sell	6,430 -100	-2%	-$7.52K	0.28%	65
2024 Q2	$447K	Sell	6,530 -550	-8%	-$38.1K	0.18%	69
2024 Q1	$490K	Sell	7,080 -340	-5%	-$23.4K	0.19%	72
2023 Q4	$531K	Sell	7,420 -116,260	-94%	-$6.69M	0.23%	75
2023 Q3	$6.44M	Buy	123,680 +3,828	+3%	+$223K	1.25%	27
2023 Q2	$7.59M	Buy	119,852 +5,652	+5%	+$352K	1.27%	29
2023 Q1	$6.18M	Sell	114,200 -8,250	-7%	-$399K	1.19%	30
2022 Q4	$6.48M	Hold	122,450	–	–	1.25%	28
2022 Q3	$5.7M	Buy	122,450 +31,650	+35%	+$1.65M	1.12%	35
2022 Q2	$5.18M	Buy	+90,800	New	+$5.15M	1.04%	42
2020 Q3	–	Sell	-8,400	Closed	-$216K	–	183
2020 Q2	$216K	Buy	+8,400	New	+$170K	0.02%	180

Other funds holding ITCI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Sectoral Asset Management's ITCI Position: Q1 2025 in Review

Sectoral Asset Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 4,900 shares — an estimated $409K sold.

Sectoral Asset Management first reported a position in ITCI in Q2 2020 and held it in 12 quarters. The position peaked at $7.59M in Q2 2023. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

Sectoral Asset Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
Sectoral Asset Management sold 4,900 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $409K.
Sectoral Asset Management first reported a position in Intra-Cellular Therapies Inc. in Q2 2020 and held it in 12 quarters.
Sectoral Asset Management's Intra-Cellular Therapies Inc. position peaked at $7.59M in Q2 2023.
395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Sectoral Asset Management's 13F filing for Q1 2025, filed 15 May 2025.